Insider Trading Arrangements |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2024
shares
|
Mar. 31, 2024
shares
|
|
Trading Arrangements, by Individual | ||
Rule 10b5-1 Arrangement Adopted | true | |
Non-Rule 10b5-1 Arrangement Adopted | false | |
Rule 10b5-1 Arrangement Terminated | false | |
Non-Rule 10b5-1 Arrangement Terminated | false | |
Joseph B. Armes [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On November 17, 2023, Joseph B. Armes, Chairman, Chief Executive Officer and President of the Company, entered into an amended Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K promulgated under the Exchange Act), the terms of which mirror his prior Rule 10b5-1 trading agreement that terminated in December 2023. The amended trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. Under the amended trading agreement, Mr. Armes may sell in the open market at prevailing prices on specified dates (subject to minimum price thresholds) an aggregate of up to 12,000 shares of the Company’s common stock. The shares are intended to be sold on a monthly basis in equal installments, to the extent practicable. Any sales under the trading arrangement will be made during the period beginning February 20, 2024 until the Plan terminates in January 2025.
|
|
Name | Joseph B. Armes | |
Title | Chairman, Chief Executive Officer and President | |
Adoption Date | November 17, 2023 | |
Arrangement Duration | 346 days | |
Aggregate Available | 12,000 | 12,000 |